Unofficial. This site is an experimental reformatting of data published by NHS England. It is not endorsed by NHS England. Always check the official Data Uses Register before relying on anything here.

Favourable Outcome of canceR Therapy (ODR1920_062)

The University of Manchester · Academic

Expired The latest version ended on 28 June 2024. The September 2026 register still lists the agreement, but its term has passed.

Reference
DARS-NIC-656854-T9G6P
Latest version
v1.3
Term of latest version
24 March 2023 to 28 June 2024
Start date
Before 24 March 2023
Data controller
Sole Data Controller
Commercial purposes
No
Sublicensing
No
Files released to date
0

Why the data was released

Objective for processing

Historical Data Processing

PHE sent the FORTY study team the requested dataset to process as follows:

1) Separate any patients with a death record within 5 years of treatment and

hold as cohort 2

2) Exclude any patients where the treatment intent is not radical using treatment intent codes, event codes and treatment details where intent is incomplete

3) Separate any patients with another treatment record within 5 years (indicating the first round of radical treatment did not cure the cancer) and hold as

cohort 3 using the same data codes as step 2 as well as event dates

4) Count the number of patients remaining, this is our patients cured cohort,

cohort 1

5) Stratify the main cohort (cohort 1) of patients remaining by treatment modality or modalities

Cohort 3 will be sent back to step 1 so patients who were cured with a second (or

more) round of radical treatment are still included in the analysis.

Once cohort 1 has been selected and separated by treatment modalities, the contribution that each modality has to the number of cured patients will be calculated.

For the secondary research questions, cohort 1 will also be separately stratified by:

a) Cancer site

b) Deprivation (IMD quintile)

c) Ethnic group

d) Age group

Processing activities

The data will be transferred from PHE to the UoM research data storage systems via the PHE secure file exchange. If a password is required for the data file then this will be provide via a separate communication line, such as telephone call.

The data will be loaded into a SQL database, held on a University of Manchester research data storage system which meets all requirements specified by any data-sharing agreement between Public Health England and the University of Manchester. The SQL database allows the data to be extracted, filtered and sorted without modifying the data offload from NCRAS, keeping the original data the same as originally received.

Typically for this type of research, we will assume that 'cure' means 5 years of survival following treatment, without tumour recurrence or progression.

The stages of processing the data to achieve the principle research question are as follows:

1) Remove any patients with a death record within 5 years of treatment and hold them separate

2) Remove any patients where the treatment intent is not radical

3) Remove any patients with another treatment record within 5 years (indicating the first round of radical treatment did not cure the cancer)

4) Count the number of patients remaining, this is our patients cured cohort

5) Separate the cohort of patients remaining by treatment modality or modalities

Once the final cohort of patients has been selected and separated by treatment modalities, the contribution that each modality has to the number of cured patients will be calculated.

For the secondary research questions, the main results from step 5 will be separately stratified by:

a) Cancer site

b) Deprivation (IMD quintile)

c) Ethnic group

d) Age group

Additionally, the patients that have a death record will be further analysed to identify any potential cohorts that died within 6 months of radical intent treatment.

Expected output

Journal Publications and conference presentations

Expected measurable benefits

Scientific publications and conference abstracts. Updating the available data and making it more rigorous and measurable

Benefits reported so far

Abstracts at Scientific conferences

Datasets on the latest version

Legal basis for provision: Health and Social Care Act 2012 – s261(2)(a)

Datasets approved under DARS-NIC-656854-T9G6P-v1.3
DatasetType of dataSensitivity FrequencyConfidential data
NDRS Cancer Registrations Anonymised - ICO Code Compliant Sensitive One-Off Does not include the flow of confidential data
NDRS National Radiotherapy Dataset (RTDS) Anonymised - ICO Code Compliant Sensitive One-Off Does not include the flow of confidential data
NDRS Systemic Anti-Cancer Therapy Dataset (SACT) Anonymised - ICO Code Compliant Sensitive One-Off Does not include the flow of confidential data

Files released

Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.

No files recorded as released under this agreement.

Version history

The register lists each renewal of this agreement as a separate row. This site has 1 version — earlier versions exist, but none has been listed in an edition this site holds.

DARS-NIC-656854-T9G6P-v1.3 24 March 2023 to 28 June 2024
Title
Favourable Outcome of canceR Therapy (ODR1920_062)
Commercial
No
Sublicensing
No
Datasets
3
Files released
0

Datasets: NDRS Cancer Registrations; NDRS National Radiotherapy Dataset (RTDS); NDRS Systemic Anti-Cancer Therapy Dataset (SACT)

Register history

When this agreement appeared in, or was edited in, each monthly edition of the register. Built by comparing every edition this site holds.

Cite this page

NHS England (2026) Data Uses Register, September 2026 edition, agreement DARS-NIC-656854-T9G6P, “Favourable Outcome of canceR Therapy (ODR1920_062)”. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/agreements/dars-nic-656854-t9g6p/ (accessed [date]).

This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.

Source: datausesregister_september2026.xlsx, September 2026 edition of the NHS England Data Uses Register. Search that workbook for DARS-NIC-656854-T9G6P to see the original rows.